Adding Zynyz to carboplatin and paclitaxel prolonged the survival without progression in chemotherapy-naive recurrent or ...

High TILs may predict which patients with early HER2-positive breast cancer may have a reduced risk for disease relapse or ...

Patients with intermediate-stage liver cancer may benefit from receiving a Lenvima-Keytruda combination with transarterial ...

Patients with previously untreated, high-risk locally advanced cervical cancer experienced improved survival when treated ...

Study findings were mixed regarding the postsurgical combination of Keytruda and chemotherapy with or without radiation among ...

Rybrevant plus chemotherapy improved overall survival versus chemo alone in EGFR-mutant advanced non-small cell lung cancer after disease progression. Promising overall survival (OS) trends continued ...

Among patients with previously treated advanced clear cell renal cell carcinoma (RCC) Welireg continued to show some benefits ...

From Princess Kate entering ‘a new phase of recovery’ to a Rock and Roll Hall of Famer’s blood cancer announcement, here’s ...

Looking back at my experience with osteosarcoma, I realized that managing the mental game was half the battle, especially ...

The discussion will cover experiences with CLL treatment, focusing on key factors in treatment decisions, how care teams educate patients about options, strategies for discussing adverse events, and ...

The discussion will cover fixed-duration treatments vs continuous therapy for CLL and provide a brief overview of venetoclax-based regimens approved for 12 cycles with obinutuzumab and 24 cycles with ...

Tecentriq Hybreza, a subcutaneous delivery of the drug, was approved for certain types of sarcoma, in addition to lung, skin ...